Prostate cancer news
Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK.
Treating the prostate with radiotherapy alongside standard treatment led to a 11 per cent* increase in survival for some men with advanced prostate cancer.
The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.
By studying small differences in our DNA, called SNPs, our scientists are showing how these could be used to help prevent cancer in the future.
Questions are being asked of the tests used to diagnose prostate cancer, and how they can be improved. We cover the latest research, including specialist MRI.